Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Beginning Cash Balance Beginning Cash Balance Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Cost of Revenue Gross Profit Long-Term Debt Issuances Long-Term Debt Repayments Receivables - Net Receivables - Other Revenue - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments Wages, Salaries and Other

Creative Medical Technology Holdings (CELZ) Preferred Shares Issued (2021)

Creative Medical Technology Holdings has reported Preferred Shares Issued over the past 1 years, most recently at $462000.0 for Q1 2021.

Quarterly Preferred Shares Issued changed N/A to $462000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $462000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $100.0 for FY2024, N/A changed from the prior year.
Preferred Shares Issued was $462000.0 for Q1 2021 at Creative Medical Technology Holdings.
Over five years, Preferred Shares Issued peaked at $462000.0 in Q1 2021 and troughed at $462000.0 in Q1 2021.